Skip to content

Michael Heltzen, Chief Executive Officer at Exozymes, bought EXOZ on Aug 26, 2026

Data as of Oct 16

▲ BUY$1.8K251 shares at $7.35Michael Heltzen Chief Executive OfficerEXOZ Exozymes Inc.
Watch EXOZ
Traded
Aug 26, 2026
Disclosed
Sep 2, 2026
Filed
7 days after the trade · late

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Michael Heltzen, Chief Executive Officer at Exozymes, bought EXOZ on Aug 26, 2026TRADEDDISCLOSED
EXOZSimilar stocks (XLV — its sector index fund), rebased to EXOZ's price on the disclosure day
EXOZ since disclosure
−39.8%
Similar stocks (XLV) since disclosure
+2.2%
XLV — its sector index fund

Change in closing price from Sep 2, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▲ BUYMichael Heltzen Chief Executive OfficerEXOZ Exozymes Inc.$30disclosed Sep 2 · filed 7 days after the trade · late
  2. ▲ BUYMichael Heltzen Chief Executive OfficerEXOZ Exozymes Inc.$1.9Kdisclosed Sep 2 · filed 7 days after the trade · late
  3. ▲ BUYMichael Heltzen Chief Executive OfficerEXOZ Exozymes Inc.$750disclosed Sep 2 · filed 8 days after the trade · late
  4. ▲ BUYMichael Heltzen Chief Executive OfficerEXOZ Exozymes Inc.$1.9Kdisclosed Sep 2 · filed 8 days after the trade · late

See every trade on EXOZ →